Amplia Therapeutics Ltd CEO outlines 2023 milestones

Amplia Therapeutics Ltd (ASX:ATX) CEO Dr Chris Burns speaks with Proactive following his move into the leadership role late last year. Amplia is an...

Related Keywords

Australia ,Australian ,Proactiveinvestors Ampliatherapeutics ,Chris Burns ,Amplia Therapeutics Ltd ,Focal Adhesion Kinase ,